# CVS HEALTH Corp: financial statements, quarterly

CVS · NYSE · CIK 64803 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cvs.md) · [Financials](/companies/cvs/financials.md) · [Filings](/companies/cvs/filings.md) · [Insiders](/companies/cvs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cvs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [89.8](/filings/0000064803-24-000034.md) | [93.8 d](/filings/0000064803-26-000010.md) | [88.4](/filings/0000064803-25-000013.md) | [91.2](/filings/0000064803-25-000024.md) | [95.4](/filings/0000064803-25-000037.md) | [97.7 d](/filings/0000064803-26-000010.md) | [94.6](/filings/0000064803-26-000052.md) | [98.9](/filings/0000064803-26-000098.md) | [103](/filings/0000064803-25-000037.md) | [106 d](/filings/0000064803-26-000010.md) | [100](/filings/0000064803-26-000052.md) | [106](/filings/0000064803-26-000098.md) |
| Cost of revenue | $bn | [54.7](/filings/0000064803-24-000034.md) | [57.4 d](/filings/0000064803-26-000010.md) | [48.1](/filings/0000064803-25-000013.md) | [50.0](/filings/0000064803-25-000024.md) | [52.9](/filings/0000064803-25-000037.md) | [55.3 d](/filings/0000064803-26-000010.md) | [51.1](/filings/0000064803-26-000052.md) | [54.0](/filings/0000064803-26-000098.md) | [57.0](/filings/0000064803-25-000037.md) | [59.1 d](/filings/0000064803-26-000010.md) | [55.4](/filings/0000064803-26-000052.md) | [58.9](/filings/0000064803-26-000098.md) |
| Gross profit | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $bn | [3.7](/filings/0000064803-24-000034.md) | [3.4 d](/filings/0000064803-26-000010.md) | [2.3](/filings/0000064803-25-000013.md) | [3.0](/filings/0000064803-25-000024.md) | [0.8](/filings/0000064803-25-000037.md) | [2.4 d](/filings/0000064803-26-000010.md) | [3.4](/filings/0000064803-26-000052.md) | [2.4](/filings/0000064803-26-000098.md) | [(3.2)](/filings/0000064803-25-000037.md) | [2.1 d](/filings/0000064803-26-000010.md) | [4.7](/filings/0000064803-26-000052.md) | [4.7](/filings/0000064803-26-000098.md) |
| Interest expense | $bn | [0.7](/filings/0000064803-23-000047.md) | [0.7 d](/filings/0000064803-24-000007.md) | [0.7](/filings/0000064803-24-000016.md) | [0.7](/filings/0000064803-25-000024.md) | [0.8](/filings/0000064803-25-000037.md) | [0.8 d](/filings/0000064803-26-000010.md) | [0.8](/filings/0000064803-26-000052.md) | [0.8](/filings/0000064803-26-000098.md) | [0.8](/filings/0000064803-25-000037.md) | [0.8 d](/filings/0000064803-26-000010.md) | [0.8](/filings/0000064803-26-000052.md) | [0.8](/filings/0000064803-26-000098.md) |
| Income tax | $bn | [0.8](/filings/0000064803-24-000034.md) | [0.7 d](/filings/0000064803-26-000010.md) | [0.5](/filings/0000064803-25-000013.md) | [0.6](/filings/0000064803-25-000024.md) | [0.0](/filings/0000064803-25-000037.md) | [0.5 d](/filings/0000064803-26-000010.md) | [0.8](/filings/0000064803-26-000052.md) | [0.6](/filings/0000064803-26-000098.md) | [0.5](/filings/0000064803-25-000037.md) | [(1.6) d](/filings/0000064803-26-000010.md) | [1.0](/filings/0000064803-26-000052.md) | [1.0](/filings/0000064803-26-000098.md) |
| Net income | $bn | [2.3](/filings/0000064803-24-000034.md) | [2.0 d](/filings/0000064803-26-000010.md) | [1.1](/filings/0000064803-25-000013.md) | [1.8](/filings/0000064803-25-000024.md) | [0.1](/filings/0000064803-25-000037.md) | [1.6 d](/filings/0000064803-26-000010.md) | [1.8](/filings/0000064803-26-000052.md) | [1.0](/filings/0000064803-26-000098.md) | [(4.0)](/filings/0000064803-25-000037.md) | [2.9 d](/filings/0000064803-26-000010.md) | [2.9](/filings/0000064803-26-000052.md) | [3.0](/filings/0000064803-26-000098.md) |
| Diluted EPS | $ per share | [1.75](/filings/0000064803-24-000034.md) | not reported | [0.88](/filings/0000064803-25-000013.md) | [1.41](/filings/0000064803-25-000024.md) | [0.07](/filings/0000064803-25-000037.md) | not reported | [1.41](/filings/0000064803-26-000052.md) | [0.80](/filings/0000064803-26-000098.md) | [(3.13)](/filings/0000064803-25-000037.md) | not reported | [2.30](/filings/0000064803-26-000052.md) | [2.31](/filings/0000064803-26-000098.md) |
| Basic EPS | $ per share | [1.76](/filings/0000064803-24-000034.md) | not reported | [0.88](/filings/0000064803-25-000013.md) | [1.41](/filings/0000064803-25-000024.md) | [0.07](/filings/0000064803-25-000037.md) | not reported | [1.41](/filings/0000064803-26-000052.md) | [0.81](/filings/0000064803-26-000098.md) | [(3.13)](/filings/0000064803-25-000037.md) | not reported | [2.31](/filings/0000064803-26-000052.md) | [2.33](/filings/0000064803-26-000098.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [13.0](/filings/0000064803-23-000047.md) | [8.2](/filings/0000064803-26-000010.md) | [9.8](/filings/0000064803-24-000016.md) | [12.5](/filings/0000064803-24-000029.md) | [6.9](/filings/0000064803-24-000034.md) | [8.6](/filings/0000064803-26-000010.md) | [10.1](/filings/0000064803-25-000013.md) | [11.8](/filings/0000064803-25-000024.md) | [9.1](/filings/0000064803-25-000037.md) | [8.5](/filings/0000064803-26-000098.md) | [9.5](/filings/0000064803-26-000052.md) | [11.3](/filings/0000064803-26-000098.md) |
| Current assets | $bn | [70.1](/filings/0000064803-23-000047.md) | [67.9](/filings/0000064803-25-000007.md) | [67.5](/filings/0000064803-24-000016.md) | [70.0](/filings/0000064803-24-000029.md) | [67.3](/filings/0000064803-24-000034.md) | [68.6](/filings/0000064803-26-000010.md) | [73.2](/filings/0000064803-25-000013.md) | [75.6](/filings/0000064803-25-000024.md) | [77.1](/filings/0000064803-25-000037.md) | [74.7](/filings/0000064803-26-000098.md) | [74.8](/filings/0000064803-26-000052.md) | [75.3](/filings/0000064803-26-000098.md) |
| Total assets | $bn | [251](/filings/0000064803-23-000047.md) | [250](/filings/0000064803-25-000007.md) | [250](/filings/0000064803-24-000016.md) | [252](/filings/0000064803-24-000029.md) | [252](/filings/0000064803-24-000034.md) | [253](/filings/0000064803-26-000010.md) | [256](/filings/0000064803-25-000013.md) | [258](/filings/0000064803-25-000024.md) | [255](/filings/0000064803-25-000037.md) | [254](/filings/0000064803-26-000098.md) | [253](/filings/0000064803-26-000052.md) | [254](/filings/0000064803-26-000098.md) |
| Current liabilities | $bn | [81.6](/filings/0000064803-23-000047.md) | [79.2](/filings/0000064803-25-000007.md) | [83.3](/filings/0000064803-24-000016.md) | [81.4](/filings/0000064803-24-000029.md) | [84.6](/filings/0000064803-24-000034.md) | [84.6](/filings/0000064803-26-000010.md) | [89.0](/filings/0000064803-25-000013.md) | [94.2](/filings/0000064803-25-000024.md) | [92.7](/filings/0000064803-25-000037.md) | [88.7](/filings/0000064803-26-000098.md) | [86.4](/filings/0000064803-26-000052.md) | [87.0](/filings/0000064803-26-000098.md) |
| Total liabilities | $bn | [177](/filings/0000064803-23-000047.md) | [173](/filings/0000064803-25-000007.md) | [176](/filings/0000064803-24-000016.md) | [177](/filings/0000064803-24-000029.md) | [177](/filings/0000064803-24-000034.md) | [177](/filings/0000064803-26-000010.md) | [178](/filings/0000064803-25-000013.md) | [181](/filings/0000064803-25-000024.md) | [182](/filings/0000064803-25-000037.md) | [178](/filings/0000064803-26-000098.md) | [175](/filings/0000064803-26-000052.md) | [174](/filings/0000064803-26-000098.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | [0.2](/filings/0000064803-25-000007.md) | [2.7](/filings/0000064803-24-000016.md) | [0.0](/filings/0000064803-24-000029.md) | [0.8](/filings/0000064803-24-000034.md) | [2.1](/filings/0000064803-26-000010.md) | [1.3](/filings/0000064803-25-000013.md) | [3.0](/filings/0000064803-25-000024.md) | [1.2](/filings/0000064803-25-000037.md) | [0.0](/filings/0000064803-26-000010.md) | not reported | not reported |
| Shareholders' equity | $bn | [74.3](/filings/0000064803-23-000047.md) | [76.5](/filings/0000064803-25-000007.md) | [74.0](/filings/0000064803-24-000016.md) | [74.9](/filings/0000064803-24-000029.md) | [74.9](/filings/0000064803-24-000034.md) | [75.6](/filings/0000064803-26-000010.md) | [76.9](/filings/0000064803-25-000013.md) | [77.4](/filings/0000064803-25-000024.md) | [72.9](/filings/0000064803-25-000037.md) | [75.2](/filings/0000064803-26-000098.md) | [77.5](/filings/0000064803-26-000052.md) | [79.7](/filings/0000064803-26-000098.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,716 d](/filings/0000064803-24-000034.md) | [(2,636) d](/filings/0000064803-26-000010.md) | [4,903](/filings/0000064803-25-000013.md) | [3,089 d](/filings/0000064803-25-000024.md) | [(745) d](/filings/0000064803-25-000037.md) | [1,860 d](/filings/0000064803-26-000010.md) | [4,556](/filings/0000064803-26-000052.md) | [1,897 d](/filings/0000064803-26-000098.md) | [796 d](/filings/0000064803-25-000037.md) | [3,390 d](/filings/0000064803-26-000010.md) | [4,249](/filings/0000064803-26-000052.md) | [6,345 d](/filings/0000064803-26-000098.md) |
| Capital expenditure | $m | [545 d](/filings/0000064803-24-000034.md) | [911 d](/filings/0000064803-26-000010.md) | [705](/filings/0000064803-25-000013.md) | [638 d](/filings/0000064803-25-000024.md) | [670 d](/filings/0000064803-25-000037.md) | [768 d](/filings/0000064803-26-000010.md) | [743](/filings/0000064803-26-000052.md) | [607 d](/filings/0000064803-26-000098.md) | [698 d](/filings/0000064803-25-000037.md) | [784 d](/filings/0000064803-26-000010.md) | [849](/filings/0000064803-26-000052.md) | [691 d](/filings/0000064803-26-000098.md) |
| Dividends paid | $m | [779 d](/filings/0000064803-24-000034.md) | [779 d](/filings/0000064803-26-000010.md) | [840](/filings/0000064803-25-000013.md) | [858 d](/filings/0000064803-25-000024.md) | [837 d](/filings/0000064803-25-000037.md) | [838 d](/filings/0000064803-26-000010.md) | [840](/filings/0000064803-26-000052.md) | [866 d](/filings/0000064803-26-000098.md) | [846 d](/filings/0000064803-25-000037.md) | [845 d](/filings/0000064803-26-000010.md) | [847](/filings/0000064803-26-000052.md) | [878 d](/filings/0000064803-26-000098.md) |
| Share repurchases | $m | [(3.0) d](/filings/0000064803-24-000034.md) | [(1.0) d](/filings/0000064803-26-000010.md) | [3,027](/filings/0000064803-25-000013.md) | [(3.0) d](/filings/0000064803-25-000024.md) | [(1.0) d](/filings/0000064803-25-000037.md) | [0.0 d](/filings/0000064803-26-000010.md) | [0.0](/filings/0000064803-25-000013.md) | [0.0 d](/filings/0000064803-25-000024.md) | [0.0 d](/filings/0000064803-25-000037.md) | [0.0 d](/filings/0000064803-26-000010.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,315](/filings/0000064803-23-000047.md) | [1,291](/filings/0000064803-24-000016.md) | [1,287](/filings/0000064803-24-000029.md) | [1,290](/filings/0000064803-24-000034.md) | [1,267](/filings/0000064803-25-000013.md) | [1,259](/filings/0000064803-25-000024.md) | [1,259](/filings/0000064803-25-000037.md) | [1,264](/filings/0000064803-26-000052.md) | [1,270](/filings/0000064803-26-000098.md) | [1,269](/filings/0000064803-25-000037.md) | [1,279](/filings/0000064803-26-000052.md) | [1,287](/filings/0000064803-26-000098.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,278,970,369 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0000064803-26-000098.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.